358 related articles for article (PubMed ID: 19172989)
21. Increased progerin expression associated with unusual LMNA mutations causes severe progeroid syndromes.
Moulson CL; Fong LG; Gardner JM; Farber EA; Go G; Passariello A; Grange DK; Young SG; Miner JH
Hum Mutat; 2007 Sep; 28(9):882-9. PubMed ID: 17469202
[TBL] [Abstract][Full Text] [Related]
22. Correlated alterations in genome organization, histone methylation, and DNA-lamin A/C interactions in Hutchinson-Gilford progeria syndrome.
McCord RP; Nazario-Toole A; Zhang H; Chines PS; Zhan Y; Erdos MR; Collins FS; Dekker J; Cao K
Genome Res; 2013 Feb; 23(2):260-9. PubMed ID: 23152449
[TBL] [Abstract][Full Text] [Related]
23. [The role of lamins and mutations of LMNA gene in physiological and premature aging].
Sliwińska MA
Postepy Biochem; 2007; 53(1):46-52. PubMed ID: 17718387
[TBL] [Abstract][Full Text] [Related]
24. Towards delineating the chain of events that cause premature senescence in the accelerated aging syndrome Hutchinson-Gilford progeria (HGPS).
Dreesen O
Biochem Soc Trans; 2020 Jun; 48(3):981-991. PubMed ID: 32539085
[TBL] [Abstract][Full Text] [Related]
25. Eliminating the synthesis of mature lamin A reduces disease phenotypes in mice carrying a Hutchinson-Gilford progeria syndrome allele.
Yang SH; Qiao X; Farber E; Chang SY; Fong LG; Young SG
J Biol Chem; 2008 Mar; 283(11):7094-9. PubMed ID: 18178963
[TBL] [Abstract][Full Text] [Related]
26. Hutchinson-Gilford Progeria Syndrome: A premature aging disease caused by LMNA gene mutations.
Gonzalo S; Kreienkamp R; Askjaer P
Ageing Res Rev; 2017 Jan; 33():18-29. PubMed ID: 27374873
[TBL] [Abstract][Full Text] [Related]
27. Modulation of LMNA splicing as a strategy to treat prelamin A diseases.
Lee JM; Nobumori C; Tu Y; Choi C; Yang SH; Jung HJ; Vickers TA; Rigo F; Bennett CF; Young SG; Fong LG
J Clin Invest; 2016 Apr; 126(4):1592-602. PubMed ID: 26999604
[TBL] [Abstract][Full Text] [Related]
28. The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin.
McClintock D; Ratner D; Lokuge M; Owens DM; Gordon LB; Collins FS; Djabali K
PLoS One; 2007 Dec; 2(12):e1269. PubMed ID: 18060063
[TBL] [Abstract][Full Text] [Related]
29. Hutchinson-Gilford progeria syndrome through the lens of transcription.
Prokocimer M; Barkan R; Gruenbaum Y
Aging Cell; 2013 Aug; 12(4):533-43. PubMed ID: 23496208
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic deregulation of lamina-associated domains in Hutchinson-Gilford progeria syndrome.
Köhler F; Bormann F; Raddatz G; Gutekunst J; Corless S; Musch T; Lonsdorf AS; Erhardt S; Lyko F; Rodríguez-Paredes M
Genome Med; 2020 May; 12(1):46. PubMed ID: 32450911
[TBL] [Abstract][Full Text] [Related]
31. Activating the synthesis of progerin, the mutant prelamin A in Hutchinson-Gilford progeria syndrome, with antisense oligonucleotides.
Fong LG; Vickers TA; Farber EA; Choi C; Yun UJ; Hu Y; Yang SH; Coffinier C; Lee R; Yin L; Davies BS; Andres DA; Spielmann HP; Bennett CF; Young SG
Hum Mol Genet; 2009 Jul; 18(13):2462-71. PubMed ID: 19376814
[TBL] [Abstract][Full Text] [Related]
32. Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody.
McClintock D; Gordon LB; Djabali K
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2154-9. PubMed ID: 16461887
[TBL] [Abstract][Full Text] [Related]
33. LMNA is mutated in Hutchinson-Gilford progeria (MIM 176670) but not in Wiedemann-Rautenstrauch progeroid syndrome (MIM 264090).
Cao H; Hegele RA
J Hum Genet; 2003; 48(5):271-274. PubMed ID: 12768443
[TBL] [Abstract][Full Text] [Related]
34. A homozygous ZMPSTE24 null mutation in combination with a heterozygous mutation in the LMNA gene causes Hutchinson-Gilford progeria syndrome (HGPS): insights into the pathophysiology of HGPS.
Denecke J; Brune T; Feldhaus T; Robenek H; Kranz C; Auchus RJ; Agarwal AK; Marquardt T
Hum Mutat; 2006 Jun; 27(6):524-31. PubMed ID: 16671095
[TBL] [Abstract][Full Text] [Related]
35. LMNA-associated cardiocutaneous progeria: an inherited autosomal dominant premature aging syndrome with late onset.
Kane MS; Lindsay ME; Judge DP; Barrowman J; Ap Rhys C; Simonson L; Dietz HC; Michaelis S
Am J Med Genet A; 2013 Jul; 161A(7):1599-611. PubMed ID: 23666920
[TBL] [Abstract][Full Text] [Related]
36. Correction of cellular phenotypes of Hutchinson-Gilford Progeria cells by RNA interference.
Huang S; Chen L; Libina N; Janes J; Martin GM; Campisi J; Oshima J
Hum Genet; 2005 Dec; 118(3-4):444-50. PubMed ID: 16208517
[TBL] [Abstract][Full Text] [Related]
37. [Hutchinson-Gilford progeria syndrome: clinical and molecular analysis in an African patient].
Mutesa L; Pierquin G; Cwiny-Ay N; Buzizi P; Bours V
Rev Med Liege; 2007 Mar; 62(3):155-8. PubMed ID: 17511383
[TBL] [Abstract][Full Text] [Related]
38. Reactivation of latently infected HIV-1 viral reservoirs and correction of aberrant alternative splicing in the LMNA gene via AMPK activation: Common mechanism of action linking HIV-1 latency and Hutchinson-Gilford progeria syndrome.
Finley J
Med Hypotheses; 2015 Sep; 85(3):320-32. PubMed ID: 26115946
[TBL] [Abstract][Full Text] [Related]
39. A-type lamins and Hutchinson-Gilford progeria syndrome: pathogenesis and therapy.
Gonzalez JM; Pla D; Perez-Sala D; Andres V
Front Biosci (Schol Ed); 2011 Jun; 3(3):1133-46. PubMed ID: 21622261
[TBL] [Abstract][Full Text] [Related]
40. Farnesyltransferase inhibitor and rapamycin correct aberrant genome organisation and decrease DNA damage respectively, in Hutchinson-Gilford progeria syndrome fibroblasts.
Bikkul MU; Clements CS; Godwin LS; Goldberg MW; Kill IR; Bridger JM
Biogerontology; 2018 Dec; 19(6):579-602. PubMed ID: 29907918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
